Airway versus transbronchial biopsy and BAL in lung transplant recipients: different but complementary

Lung transplantation is now an established therapeutic intervention for end-stage cardiopulmonary disease in humans. Chronic rejection, in the form of bronchiolitis obliterans syndrome (BOS), remains the commonest cause of morbidity and mortality in those surviving more than 3 months. The pathology of BOS involves airway changes. We have evaluated the potential for endobronchial biopsies (EBB) to complement existing sampling methods used in allograft monitoring and have compared the results of EBB findings with those of bronchoalveolar lavage (BAL) and transbronchial biopsy (TBB) in 18 clinically stable patients. We found that all the EBB had inflammatory cells present but that only five TBB specimens had evidence of inflammation, with airway material being present in 78% of the TBB. Paired BAL and EBB yielded different results, with no correlations between total macrophages, lymphocytes, CD4+ cells or CD8+ cells. We conclude that endobronchial biopsies are potentially useful as an additional sample for the monitoring of inflammation in lung allografts, since they yield different, and potentially complimentary, information to bronchoalveolar lavage and transbronchial biopsy.

This article has been cited by other articles:

				S. Irani, T. Hess, M. Hofer, A. Gaspert, L. M. Bachmann, E. W. Russi, and A. Boehler Endobronchial ultrasonography for the quantitative assessment of bronchial mural structures in lung transplant recipients. Chest, February 1, 2006; 129(2): 349 - 355. [Abstract] [Full Text] [PDF]

				C Ward, I A Forrest, D M Murphy, G E Johnson, H Robertson, T E Cawston, A J Fisher, J H Dark, J L Lordan, J A Kirby, et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients Thorax, October 1, 2005; 60(10): 865 - 871. [Abstract] [Full Text] [PDF]

				B. Yates, D. M. Murphy, I. A. Forrest, C. Ward, R. M. Rutherford, A. J. Fisher, J. L. Lordan, J. H. Dark, and P. A. Corris Azithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 772 - 775. [Abstract] [Full Text] [PDF]

				C Ward, M Camara, I Forrest, R Rutherford, G Pritchard, M Daykin, A Hardman, A de Soyza, A J Fisher, P Williams, et al. Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax, May 1, 2003; 58(5): 444 - 446. [Abstract] [Full Text] [PDF]

				C. WARD, D. P. JOHNS, R. BISH, M. PAIS, D. W. REID, C. INGRAM, B. FELTIS, and E. HAYDN WALTERS Reduced Airway Distensibility, Fixed Airflow Limitation, and Airway Wall Remodeling in Asthma Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1718 - 1721. [Abstract] [Full Text] [PDF]

				C. T. LEONARD, P. M. SOCCAL, L. SINGER, G. J. BERRY, J. THEODORE, P. G. HOLT, R. L. DOYLE, and G. D. ROSEN Dendritic Cells and Macrophages in Lung Allografts . A Role in Chronic Rejection? Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1349 - 1354. [Abstract] [Full Text]

				E. GABBAY, E. HAYDN WALTERS, B. ORSIDA, H. WHITFORD, C. WARD, T. C. KOTSIMBOS, G. I. SNELL, and T. J. WILLIAMS In Stable Lung Transplant Recipients, Exhaled Nitric Oxide Levels Positively Correlate with Airway Neutrophilia and Bronchial Epithelial iNOS Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2093 - 2099. [Abstract] [Full Text]

				C. WARD, G. I. SNELL, L. ZHENG, B. ORSIDA, H. WHITFORD, T. J. WILLIAMS, and E. HAYDN WALTERS Endobronchial Biopsy and Bronchoalveolar Lavage in Stable Lung Transplant Recipients and Chronic Rejection Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 84 - 91. [Abstract] [Full Text] [PDF]